NEW YORK – Life science reagents supplier New England Biolabs said on Monday that it has agreed to acquire UK-based lyophilization R&D service company Fluorogenics.
Under the terms of the agreement, Fluorogenics will become a wholly-owned subsidiary of NEB and be part of its OEM and Customized Solutions business. Financial terms of the deal were not disclosed.
NEB currently supplies research-use-only reagents that its customers can use for further development and validation in diagnostic assays. The company said it is looking to increase its ability to offer lyophilized reagents that can withstand ambient shipping and storage.
"The acquisition of [Fluorogenics] enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers," NEB CEO Jim Ellard said in a statement. "It also further solidifies our ability to service customers in the molecular diagnostics space."